BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
See today's BioWorld
Home
» Other news to note for Dec. 1, 2021
X
Upgrade your daily dose of biopharma and medtech news
Subscribe to BioWorld™ news services
See subscription options
To read the full article
sign up for free
or
sign in
.
Other news to note for Dec. 1, 2021
Dec. 1, 2021
No Comments
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Cellevolve, Epivax, Eurocrine, Everest, Gensight, Greenlight, IFM, Immunome, Inmune, Janssen, Novartis, Noxopharm, Oragenics, Oravax, Origimm, Orion, Premas, Providence, Samus, Sanofi, Suono, Tempus, Trefoil, Verndari, Zymeworks.
BioWorld
Briefs
Other news to note
Coronavirus